Adalta Ltd has released a press release.
Inhaled AD-214 preclinical program
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from AdAlta
- PAC Partners Healthcare Conference - Corporate Presentation
- $1.6M Second Tranche R&D Cash Flow Loan Received
- Chinese patent granted for AD-214
- Change in Director Interest Notice x 4
- Application for quotation of securities - 1AD
Later from AdAlta
- Indian patent for AD-214
- AdAlta presentation at Bioshares Biotech Summit
- BIO International Convention presentation
- European Patent for AD-214 granted
- AD-214 program update, cash runway extension
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta